Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy

Q Yang, OS Madueke-Laveaux, H Cun, M Wlodarczyk… - Cells, 2024 - mdpi.com
Uterine leiomyosarcoma (uLMS) is the most common subtype of uterine sarcomas. They
have a poor prognosis with high rates of recurrence and metastasis. The five-year survival …

Epigenetic features in uterine leiomyosarcoma and endometrial stromal sarcomas: an overview of the literature

BC de Almeida, LG Dos Anjos, AS Dobroff, EC Baracat… - Biomedicines, 2022 - mdpi.com
There is a consensus that epigenetic alterations play a key role in cancer initiation and its
biology. Studies evaluating the modification in the DNA methylation and chromatin …

Bromodomain-containing protein 9 regulates signaling pathways and reprograms the epigenome in immortalized human uterine fibroid cells

Q Yang, S Vafaei, A Falahati, A Khosh… - International journal of …, 2024 - mdpi.com
Bromodomain-containing proteins (BRDs) are involved in many biological processes, most
notably epigenetic regulation of transcription, and BRD dysfunction has been linked to many …

Targeting class I histone deacetylases in human uterine leiomyosarcoma

Q Yang, A Falahati, A Khosh, H Mohammed, W Kang… - Cells, 2022 - mdpi.com
Uterine leiomyosarcoma (uLMS) is the most frequent subtype of uterine sarcoma that
presents a poor prognosis, high rates of recurrence, and metastasis. Currently, the …

The role of microRNAs in uterine leiomyosarcoma diagnosis and treatment

I Psilopatis, K Vrettou, S Kokkali, S Theocharis - Cancers, 2023 - mdpi.com
Simple Summary MicroRNAs (miRNAs) show differential expression in various cancer
entities and seemingly contribute to cancer development and/or progression. Nevertheless …

Targeting SWI/SNF complexes in cancer: pharmacological approaches and implications

MR Dreier, J Walia, IL de la Serna - Epigenomes, 2024 - mdpi.com
SWI/SNF enzymes are heterogeneous multi-subunit complexes that utilize the energy from
ATP hydrolysis to remodel chromatin structure, facilitating transcription, DNA replication, and …

[HTML][HTML] Unraveling the Role of Bromodomain and Extra-Terminal Proteins in Human Uterine Leiomyosarcoma

Q Yang, A Falahati, A Khosh, RR Lastra, TG Boyer… - Cells, 2024 - mdpi.com
Uterine leiomyosarcoma (uLMS) is the most common type of uterine sarcoma, associated
with poor prognosis, high rates of recurrence, and metastasis. Currently, the molecular …

Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma

N Garcia, M Ulin, Q Yang, M Ali, MC Bosland, W Zeng… - Cells, 2023 - mdpi.com
Leiomyosarcoma (LMS) has been challenging to diagnose because of limitations in clinical
and radiographic predictors, as well as the lack of reliable serum or urinary biomarkers. Most …

Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies

M Ciebiera, J Kociuba, M Ali… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Uterine fibroids, the most common nonmalignant tumors affecting the female
genital tract, are a significant medical challenge. This article focuses on the most recent …

TPPP-BRD9 fusion-related gallbladder carcinomas are frequently associated with intracholecystic neoplasia, neuroendocrine carcinoma, and a distinctive small …

B Pehlivanoglu, JC Araya, S Lawrence, JC Roa… - Human Pathology, 2024 - Elsevier
A fusion between tubulin polymerization-promoting protein (TPPP), a regulatory cytoskeletal
gene, and the chromatin remodeling factor, bromodomain-containing protein 9 (BRD9) …